• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

达沙替尼与 MHI-148 的缀合在胶质母细胞瘤细胞活力检测中具有显著的有利效果。

Conjugation of Dasatinib with MHI-148 Has a Significant Advantageous Effect in Viability Assays for Glioblastoma Cells.

机构信息

Department of Chemistry, Texas A&M University, Box 30012, College Station, TX, 77842, USA.

Department of Molecular & Cellular Medicine, Texas A&M University Health Science Center, College Station, TX, 77843, USA.

出版信息

ChemMedChem. 2019 Sep 4;14(17):1575-1579. doi: 10.1002/cmdc.201900356. Epub 2019 Aug 7.

DOI:10.1002/cmdc.201900356
PMID:31322832
Abstract

We hypothesized that conjugation of the near-infrared dye MHI-148 with the anti-leukemia drug dasatinib might produce a potential theranostic for glioblastoma. In fact, the conjugate was found to bind the kinases Src and Lyn, and to inhibit the viability of a glioblastoma cell line with significantly greater potency than dasatinib alone, MHI-148 alone, or a mixture of dasatinib and MHI-148 at the same concentration. It was also used to successfully image a subcutaneous glioblastoma tumor in vivo.

摘要

我们假设将近红外染料 MHI-148 与白血病药物达沙替尼缀合可能产生胶质母细胞瘤的潜在治疗诊断试剂。事实上,该缀合物被发现与激酶Src 和 Lyn 结合,并以比单独的达沙替尼、单独的 MHI-148 或相同浓度的达沙替尼和 MHI-148 混合物更显著的效力抑制胶质母细胞瘤细胞系的活力。它还成功地用于体内成像皮下胶质母细胞瘤肿瘤。

相似文献

1
Conjugation of Dasatinib with MHI-148 Has a Significant Advantageous Effect in Viability Assays for Glioblastoma Cells.达沙替尼与 MHI-148 的缀合在胶质母细胞瘤细胞活力检测中具有显著的有利效果。
ChemMedChem. 2019 Sep 4;14(17):1575-1579. doi: 10.1002/cmdc.201900356. Epub 2019 Aug 7.
2
Src family kinases differentially influence glioma growth and motility.Src家族激酶对胶质瘤的生长和运动性有不同影响。
Mol Oncol. 2015 Nov;9(9):1783-98. doi: 10.1016/j.molonc.2015.06.001. Epub 2015 Jun 10.
3
LYN expression predicts the response to dasatinib in a subpopulation of lung adenocarcinoma patients.LYN表达可预测一部分肺腺癌患者对达沙替尼的反应。
Oncotarget. 2016 Dec 13;7(50):82876-82888. doi: 10.18632/oncotarget.12657.
4
A multifunctional heptamethine near-infrared dye for cancer theranosis.一种多功能的七甲川近红外染料用于癌症治疗。
Biomaterials. 2013 Mar;34(9):2244-51. doi: 10.1016/j.biomaterials.2012.11.057. Epub 2012 Dec 20.
5
Cytoprotective agent troxipide-cyanine dye conjugate with cytotoxic and antiproliferative activity in patient-derived glioblastoma cell lines.具有细胞毒性和抗增殖活性的细胞保护剂曲昔匹特-花青染料缀合物在患者来源的胶质母细胞瘤细胞系中。
Bioorg Med Chem Lett. 2021 Oct 15;50:128336. doi: 10.1016/j.bmcl.2021.128336. Epub 2021 Aug 24.
6
Cabozantinib and dastinib exert anti-tumor activity in alveolar soft part sarcoma.卡博替尼和达沙替尼在肺泡软组织肉瘤中发挥抗肿瘤活性。
PLoS One. 2017 Sep 25;12(9):e0185321. doi: 10.1371/journal.pone.0185321. eCollection 2017.
7
Involvement of the tumour necrosis factor receptor system in glioblastoma cell death induced by palbociclib-heptamethine cyanine dye conjugate.帕博西尼-七甲川花菁染料缀合物诱导胶质母细胞瘤细胞死亡过程中肿瘤坏死因子受体系统的参与。
Cell Commun Signal. 2024 Jan 11;22(1):30. doi: 10.1186/s12964-023-01277-z.
8
Cyanine-Gemcitabine Conjugates as Targeted Theranostic Agents for Glioblastoma Tumor Cells.菁染料-吉西他滨偶联物作为胶质母细胞瘤肿瘤细胞的靶向治疗剂。
J Med Chem. 2019 Oct 24;62(20):9236-9245. doi: 10.1021/acs.jmedchem.9b01147. Epub 2019 Oct 11.
9
Monitoring Src status after dasatinib treatment in HER2+ breast cancer with Zr-trastuzumab PET imaging.Zr-曲妥珠单抗 PET 显像监测曲达西他滨治疗后 HER2+乳腺癌中的Src 状态。
Breast Cancer Res. 2018 Oct 25;20(1):130. doi: 10.1186/s13058-018-1055-2.
10
Identification and validation of phospho-SRC, a novel and potential pharmacodynamic biomarker for dasatinib (SPRYCEL), a multi-targeted kinase inhibitor.磷酸化SRC的鉴定与验证,一种针对多靶点激酶抑制剂达沙替尼(施达赛)的新型潜在药效学生物标志物。
Cancer Chemother Pharmacol. 2008 Nov;62(6):1065-74. doi: 10.1007/s00280-008-0699-5. Epub 2008 Feb 27.

引用本文的文献

1
Molecular Pharmacology of Dasatinib Provides Unique Insights into the Mechanistic Basis of Success and Failure of Targeted Cancer Therapy.达沙替尼的分子药理学为深入了解靶向癌症治疗成败的机制基础提供了独特视角。
ACS Pharmacol Transl Sci. 2024 Dec 6;8(1):1-9. doi: 10.1021/acsptsci.4c00492. eCollection 2025 Jan 10.
2
Design Principles and Applications of Fluorescent Kinase Inhibitors for Simultaneous Cancer Bioimaging and Therapy.用于同步癌症生物成像与治疗的荧光激酶抑制剂的设计原理及应用
Cancers (Basel). 2024 Oct 30;16(21):3667. doi: 10.3390/cancers16213667.
3
Involvement of the tumour necrosis factor receptor system in glioblastoma cell death induced by palbociclib-heptamethine cyanine dye conjugate.
帕博西尼-七甲川花菁染料缀合物诱导胶质母细胞瘤细胞死亡过程中肿瘤坏死因子受体系统的参与。
Cell Commun Signal. 2024 Jan 11;22(1):30. doi: 10.1186/s12964-023-01277-z.
4
Cyanine Dye Conjugation Enhances Crizotinib Localization to Intracranial Tumors, Attenuating NF-κB-Inducing Kinase Activity and Glioma Progression.菁染料缀合增强克唑替尼向颅内肿瘤的定位,抑制 NF-κB 诱导的激酶活性和神经胶质瘤进展。
Mol Pharm. 2023 Dec 4;20(12):6140-6150. doi: 10.1021/acs.molpharmaceut.3c00496. Epub 2023 Nov 8.
5
Conjugation of Palbociclib with MHI-148 Has an Increased Cytotoxic Effect for Breast Cancer Cells and an Altered Mechanism of Action.帕博西尼与 MHI-148 缀合具有增强的乳腺癌细胞细胞毒性作用和改变的作用机制。
Molecules. 2022 Jan 27;27(3):880. doi: 10.3390/molecules27030880.
6
Fluorescent kinase inhibitors as probes in cancer.荧光激酶抑制剂作为癌症研究中的探针
Chem Soc Rev. 2021 Sep 7;50(17):9794-9816. doi: 10.1039/d1cs00017a. Epub 2021 Jul 22.
7
A heptamethine cyanine dye serves as a potential marker for myeloid-derived suppressor cells.一种七甲川花菁染料可作为髓源性抑制细胞的潜在标志物。
Am J Cancer Res. 2021 Jun 15;11(6):2853-2866. eCollection 2021.
8
The Use of Heptamethine Cyanine Dyes as Drug-Conjugate Systems in the Treatment of Primary and Metastatic Brain Tumors.七甲川花菁染料作为药物偶联系统在原发性和转移性脑肿瘤治疗中的应用
Front Oncol. 2021 Jun 1;11:654921. doi: 10.3389/fonc.2021.654921. eCollection 2021.
9
Cyanine conjugates in cancer theranostics.用于癌症诊疗的花菁缀合物。
Bioact Mater. 2020 Sep 29;6(3):794-809. doi: 10.1016/j.bioactmat.2020.09.009. eCollection 2021 Mar.